发布文献求助

威武的板凳

Lv1

100 积分 2023-05-05 加入

最近求助
最近应助
互助留言

Emerging treatment for Sjögren’s disease: a review of recent phase II and III trials 2年前 已关闭
Safety and Efficacy of Single Dose VAY736 (anti-BAFF-R mAb) in Patients with Primary Sjogren's Syndrome (pSS) 2年前 已关闭
double-blind, randomized study of vay736 single dose treatment in patients with primary sjogren's syndrome (pss) 2年前 已关闭
Advancing Biologic Therapy for Refractory Autoimmune Hepatitis 2年前 已完结
AB0509 Identification of novel biomarkers associated with disease activity of primary sjÖgren's syndrome and clinical response to vay736 2年前 已关闭
Ianalumab (VAY736), a Dual Mode of Action Biologic Combining BAFF Receptor Inhibition with B Cell Depletion, for Treatment of Primary Sjogren's Syndrome: Results of an International Randomized, Placebo Controlled Dose Range Finding Study in 190 Patients 2年前 已关闭
IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN'S SYNDROME: 52 WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL 2年前 已关闭
SERUM AUTOANTIBODY PROFILING OF PRIMARY SJOGREN'S SYNDROME PATIENTS REVEALS NOVEL BIOMARKERS ASSOCIATED WITH THE DISEASE, DISEASE ACTIVITY, AND CLINICAL RESPONSE TO VAY736 2年前 已关闭
Using Multi-modal Ultrasound to Assess Disease Activity Within the Salivary Glands of Patients with Primary Sjogren's Syndrome Treated with Ianalumab (VAY736) 2年前 已关闭

没有进行任何应助

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

Copyright © 2020-2025 AbleSci.COM, 科研通, All Right Reserved

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：941272744【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通